On-Demand Webcast


Share

Program Content

Activities

  • Targeted ADCs in NSCLC
    Optimizing NSCLC Treatment: Potential of ADCs Targeting HER2, HER3, and TROP-2
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 05, 2024

    Expires: February 04, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.